A Lipid Core Peptide Construct Containing a Conserved Region Determinant of the Group A Streptococcal M Protein Elicits Heterologous Opsonic Antibodies
- 1 May 2002
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (5) , 2734-2738
- https://doi.org/10.1128/iai.70.5.2734-2738.2002
Abstract
The study reported here investigated the immunogenicity and protective potential of a lipid core peptide (LCP) construct containing a conserved region determinant of M protein, defined as peptide J8. Parenteral immunization of mice with LCP-J8 led to the induction of high-titer serum immunoglobulin G J8-specific antibodies when the construct was coadministered with complete Freund9s adjuvant (CFA) or administered alone. LCP-J8 in CFA had significantly enhanced immunogenicity compared with the monomeric peptide J8 given in CFA. Moreover, LCP-J8/CFA and LCP-J8 antisera opsonized four different group A streptococcal (GAS) strains, and the antisera did not cross-react with human heart tissue proteins. These data indicate the potential of an LCP-based M protein conserved region GAS vaccine in the induction of broadly protective immune responses in the absence of a conventional adjuvant.Keywords
This publication has 29 references indexed in Scilit:
- T-Cell Reactivity against Streptococcal Antigens in the Periphery Mirrors Reactivity of Heart-Infiltrating T Lymphocytes in Rheumatic Heart Disease PatientsInfection and Immunity, 2001
- Induction of Autoimmune Valvular Heart Disease by Recombinant Streptococcal M ProteinInfection and Immunity, 2001
- Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzeesEuropean Journal of Immunology, 1997
- Recombinant, octavalent group A streptococcal M protein vaccineVaccine, 1996
- Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responsesVaccine, 1994
- Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococciThe Lancet, 1994
- Group A streptococcal M proteins: virulence factors and protective antigensImmunology Today, 1992
- In situ neutralization in Boc‐chemistry solid phase peptide synthesisInternational Journal of Peptide and Protein Research, 1992
- In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccineNature, 1989
- Multiple, heart-cross-reactive epitopes of streptococcal M proteins.The Journal of Experimental Medicine, 1985